0.250
-0.01 (-1.96%)
| Penutupan Terdahulu | 0.255 |
| Buka | 0.250 |
| Jumlah Dagangan | 621,500 |
| Purata Dagangan (3B) | 515,411 |
| Modal Pasaran | 195,409,584 |
| Harga / Pendapatan (P/E TTM) | 25.00 |
| Harga / Jualan (P/S) | 2.57 |
| Harga / Buku (P/B) | 1.54 |
| Julat 52 Minggu | |
| Hasil Dividen (DY TTM) | 0.80% |
| Margin Keuntungan | 6.33% |
| Margin Operasi (TTM) | 13.78% |
| EPS Cair (TTM) | 0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -34.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -39.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 13.30% |
| Nisbah Semasa (MRQ) | 7.11 |
| Aliran Tunai Operasi (OCF TTM) | 9.82 M |
| Pulangan Atas Aset (ROA TTM) | 4.93% |
| Pulangan Atas Ekuiti (ROE TTM) | 5.98% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Packaged Foods (MY) | Menaik | Menurun |
| Packaged Foods (Global) | Bercampur | Menurun | |
| Stok | SUNZEN | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -1.0 |
| Purata | 1.40 |
|
Sunzen Group Bhd Formerly Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Pharmaceutical and medical goods; Traditional Chinese medicines and herbal health foods and beverages; and Loan Financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment. Geographically, it operates into Malaysia, China, Singapore, and Others, out of which China generates maximum revenue. |
|
| Sektor | Consumer Defensive |
| Industri | Packaged Foods |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 59.77% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| MR CHEN KHAI VOON | - | - | 0 | 0 |
| SUNZEN GROUP BERHAD | 0.250 | - | 4,750,000 | 1,187,500 |
| Jumlah Keseluruhan Kuantiti Bersih | 4,750,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,187,500 | |||
| Purata Pembelian Keseluruhan ($) | 0.250 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MR CHEN KHAI VOON | Pemegang Saham Besar | 04 Mar 2026 | Notis kepentingan | 32,700,950 | - | - |
| SUNZEN GROUP BERHAD | Syarikat | 03 Mar 2026 | Pembelian semula (+) | 4,750,000 | 0.250 | 1,187,500 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Mar 2026 | TheEdge | Genetec co-founder Aaron Chen emerges as substantial shareholder in Sunzen |
| 05 Mar 2026 | TheEdge | NexG, BAT, Paramount, Sunview, Magma, InNature, EPB, Ireka, Genetec & Poh Huat |
| Hasil Dividen (DY TTM) | 0.80% |
| Jangkaan Pembayaran Dividen Seterusnya | Jan 2027 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 12 Dec 2025 | 26 Nov 2025 | 12 Jan 2026 | 0.002 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2026 | 0.002 | 1 | 0.80 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |